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AbstrACt
Objective This study aims to estimate the technical 
efficiency of health systems in Asia.
settings The study was conducted in Asian countries.
Methods We applied an output-oriented data 
envelopment analysis (DEA) approach to estimate the 
technical efficiency of the health systems in Asian 
countries. The DEA model used per-capita health 
expenditure (all healthcare resources as a proxy) as 
input variable and cross-country comparable health 
outcome indicators (eg, healthy life expectancy at birth 
and infant mortality per 1000 live births) as output 
variables. Censored Tobit regression and smoothed 
bootstrap models were used to observe the associated 
factors with the efficiency scores. A sensitivity analysis 
was performed to assess the consistency of these 
efficiency scores.
results The main findings of this paper demonstrate 
that about 91.3% (42 of 46 countries) of the studied Asian 
countries were inefficient with respect to using healthcare 
system resources. Most of the efficient countries belonged 
to the high-income group (Cyprus, Japan, and Singapore) 
and only one country belonged to the lower middle-income 
group (Bangladesh). Through improving health system 
efficiency, the studied high-income, upper middle-income, 
low-income and lower middle-income countries can 
improve health system outcomes by 6.6%, 8.6% and 
8.7%, respectively, using the existing level of resources. 
Population density, bed density, and primary education 
completion rate significantly influenced the efficiency 
score.
Conclusion The results of this analysis showed 
inefficiency of the health systems in most of the Asian 
countries and imply that many countries may improve 
their health system efficiency using the current level of 
resources. The identified inefficient countries could pay 
attention to benchmarking their health systems within 
their income group or other within similar types of health 
systems.
bACkgrOund  
In Asia, there are approximately 4.4 billion 
people spread across highly diverse coun-
tries, from economic powerhouses like 
China and Singapore to poorer economies 
such as Laos, Cambodia and Myanmar.1 
Overall, the continent is often cited as the 
fastest growing and most dynamic region in 
the world. Over the past number of years, 
Asian societies have also made impressive 
progress in ensuring better healthcare 
services, especially those targeted towards 
improving maternal and infant health 
and increasing life expectancy.2 However, 
whether economic gains have translated to 
efficient health systems across the region is 
still not well studied.
It is important that the healthcare 
resources in Asia are used efficiently. In 
Asia, generally government spending on 
healthcare is low compared with total 
health expenditure, and it is often not 
focused on those who need it most.3 For 
example, in the South Asia region, govern-
ments spend 31% of total health expendi-
ture, which is about 1% of gross domestic 
product (GDP).4 5 In many Asian countries, 
personal health expenses or out-of-pocket 
payments are a major cause of poverty.1 6 
For instance, from a study of 11 Asian coun-
tries, it was found that 78 million people are 
pushed  into poverty due to out-of-pocket 
spending for healthcare.7 Ageing popula-
tions and non-communicable diseases that 
are often preventable but expensive to treat 
(eg, diabetes and cancers linked to tobacco) 
strengths and limitations of this study
 ► Data envelopment analysis was used to determine 
the extent of inefficiency in health systems across 
Asia.
 ► We extracted health systems level indicators from 
the widely used World Bank World Development 
Indicators database and the WHO Open Data 
Repository.
 ► Due to data unavailability, we used health system 
outcomes in addressing the health systems efficien-
cy rather than true health system output.
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impose and will continue to impose heavy costs on 
households and public health budgets. Moreover, a 
major challenge for Asian countries is the control and 
prevention of different communicable diseases (eg, 
HIV/AIDS, tuberculosis and polio) due to the move-
ment of people across borders and the exchange of 
goods.8
In light of this, it is very important that the health 
systems of these countries are efficient in using their 
resources. The WHO has estimated that due to ineffi-
ciency about 20%–40% of total healthcare resources 
are being wasted per year among its member countries. 
Furthermore, this rate is higher in low-income and 
middle-income countries.9 In Asia, the variation in effi-
ciency across income groups and contexts can perhaps 
lead to lessons learnt in addressing it. In order to address 
inefficiency, Asia’s health systems can look towards 
different dimensions of performance such as their 
effectiveness, efficiency, access, equity and quality.10 A 
great deal of practitioner and academic literature have 
analysed the relationship between the efficient produc-
tion of health services and universal health coverage as 
well as the widespread importance of measuring overall 
health system performance.9 11
Assessing the efficiency of healthcare systems is a diffi-
cult process as analyses often encounter methodological 
problems, particularly due to the need for appropriate 
and valid outcome indicators.12 Despite the empirical 
difficulties in applying efficiency concepts to health 
systems, efficiency can be measured on both micro and 
macro levels.13 Measuring health system efficiency at a 
macro level is particularly important in order to under-
stand health system performance across the globe and 
take required action to minimise inefficiency.11 14
A number of studies have analysed the healthcare 
efficiency in the Americas,15 16 Western Europe17 18 
and Asia19 20 to shed light on the efficiency of different 
national healthcare systems. A systematic review on 
measuring efficiency related to several aspects of 
healthcare performed by Hollingsworth et al.21 Dimas et 
al22 evaluated the productivity of Greek public hospitals 
and found that productivity changes were dominated by 
technical change. Additionally, Zere et al 23 measured 
the technical efficiency and productivity of hospitals in 
South Africa and examined the impact of hospital char-
acteristics on efficiency and productivity.23
Several studies have reported on different determi-
nants of health system efficiency. For example, a study 
conducted in China reported that GDP per capita, 
proportion of primary health worker and population 
density were the key determinants of the efficiency in 
Chinese health system.24 Another study in the Canadian 
context reported that readmission, obesity and smoking 
and average income of the population are key determi-
nants of health system efficiency.25
In an international study of efficiency in 170 Asian 
and non-Asian countries, it was observed that Asian 
countries were comparatively in the middle with respect 
to health system efficiency scores.26 This indicates that 
there is room for improvement to optimise health bene-
fits from the available health sector resources. In this 
region, a number of studies have been conducted at the 
country level to address health systems efficiency,27 28 
but cross-country comparison of the health system effi-
ciency is limited.29
Asian countries are not homogeneous in terms of 
area, population and economic conditions; however, 
they have public health functions and a number of 
their health system outcomes are in common.30 Many 
of the countries share similar health systems prob-
lems, including a high burden of diseases due to the 
geographical contiguity, disease patterns and social 
conditions and inadequate resources for healthcare. 
Understanding health systems efficiency in different 
Asian countries could promote shared learning and 
highlight key areas of best practice, as well as areas 
where improvement is needed. Furthermore, given 
geographical proximity and many strong relationships 
experienced with nearby countries, there is likely to 
be relative ease in the ability to practically understand, 
learn and apply nuance about healthcare systems from 
one country to another.
A study on the efficiency of health systems in this 
region will help to provide lessons through comparison 
across countries. This paper aims to achieve this goal 
through measuring the technical efficiency and scale 
efficiency of the healthcare systems of selected Asian 
countries.
MethOds
This study employed two stages of efficiency analysis using 
cross-sectional data. In the first stage, data envelopment 
analysis (DEA) was used to estimate the country efficiency 
scores. In the second stage, a regression analysis and a 
bootstrap method were employed to identify the factors 
associated with the health system efficiency. The software 
package STATA V.13 was used for all of the analyses.
data sources
We used two main data sources: the WHO Data Repos-
itory31 and World Development Indicators-2015 (WDI). 
According to the list of United Nations Statistics Division, 
there are 50 Asian countries and territories. Among these, 
46 were used for this study.32 Four countries and territo-
ries (Hong Kong, North Korea, Macao, and West bank 
and Gaza) were excluded due to missing data of selected 
variables in the WDI database.5 However, selected vari-
ables for the study countries were not reported in WDI 
for every year. This problem is unavoidable in studies 
based on WDI data.33–35 Earlier studies adopted two 
approaches to deal with such problem. First, they used 
a value from a slightly earlier year as in Anderson et al33 
and second, they used a smaller number of countries in 
the model as in Färe et al34 and Grubaugh and Santerre.35 
Given the importance of including as many countries as 
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possible to study technical efficiency using DEA, we opted 
for the first approach. However, to avoid missing variable, 
we used slightly earlier WDI statistics.
Input and output variables
A main assumption of the DEA model used in our anal-
ysis was that in Asian countries, the selected health 
outcomes are dependent on the inputs of healthcare 
resources. We selected the input variables as proxies for 
the quantity of inputs that a country devotes to health-
care (ie, health expenditure per capita) and outcome 
variables as the healthy life expectancy at birth (HALE) 
and infant mortality (per 1000 live births). The health 
expenditure per capita was extracted from the Global 
Health Expenditure database managed by the WHO. 
In this database, there are national health expenditure 
statistics for more than 190 WHO Member States in line 
with the new System of Health Accounts 2011 (SHA 
2011) framework. The SHA 2011 framework was devel-
oped by Organisation for Economic Co-operation and 
Development (OECD) to rigorously track health expen-
diture (eg, by all financial sources, by all services) at the 
national level and to enable comparability across coun-
tries. The capital expenditure (eg, infrastructure) was 
included in the total health expenditure estimation.31 
The relationship between health expenditure and 
outcomes considered here is consistent with the view that 
health expenditure has diminishing returns, or addi-
tional expenditure beyond a certain level has relatively 
smaller incremental effect on life expectancy or infant 
mortality.36 To be clear, reduction in infant mortality 
and increase in life expectancy signify improvement in 
the health outcomes of a country. Some studies have 
included life expectancy at birth as an outcome vari-
able37–39; however, it is argued that quality of life matters 
as much as, if not more than, quantity of life, and there-
fore, life expectancy should be a weighted health quality 
measure. As a result, HALE has been incorporated as a 
proxy of health quality as the outcome of health systems. 
Also, it is important to note that instead of using the 
infant mortality directly in the DEA model, we used the 
inverse of infant mortality as the model assumes that 
inputs and outputs are isotonic (ie, increased input 
reduces efficiency as well as increased output increases 
efficiency).40 Without this correction, a higher infant 
mortality figure would have been said to incorrectly 
contribute to a better health system outcome.
Data envelopment analysis
DEA is a widely used non-parametric method that iden-
tifies an efficiency frontier by using linear programming 
techniques and the distance of each decision-making 
unit (DMU) to the frontier. Of the two types of effi-
ciency analysis approach namely DEA and Stochastic 
Frontier Analysis, we choose DEA. The key advantage of 
the DEA approach in this analysis is that it can incorpo-
rate multiple inputs and outputs, which are measured in 
different units.
One type of DEA model, developed by Charnes, 
Cooper and Rhodes (CCR), assumes that production has 
constant returns to scale (CRS), meaning any change 
in the input will result in a proportionate change in the 
output.41 Another model proposed by Banker, Charnes 
and Cooper (BCC) assumes that production has vari-
able returns to scale (VRS) implying an increase in the 
input will result in either an increase or a decrease in the 
output. The latter methodology is particularly useful for 
this study since it aims to measure the efficiency related 
to organisational units (ie, the health systems of different 
countries), which use numerous resources to produce 
multiple outputs and accommodate a more flexible 
assumption of VRS.26 42 This is more realistic and reflec-
tive of changes in the real world.27
We measured scale efficiency to see whether the 
health systems of Asian countries are operating at their 
optimal sizes or not.43 The size of health systems is a 
major political decision in Asian countries. To some 
extent, it depends on how the policy makers or govern-
ment are prioritising health among other competing 
public services (eg, education, military and elec-
tricity).44 Scale efficiency scores provide information on 
the optimality of a DMU size; in this case, the health 
system of a country. When a production unit (DMU) 
operates at CRS, technical efficiency is equal to scale 
efficiency. However, when DMUs are not operating at 
optimum scale, technical efficiency measured with the 
CCR model may be altered by scale efficiency. The 
BCC model, which defines production through VRS, 
can incorporate the impact of scale efficiency in the 
measurement of technical efficiency. The scale effi-
ciency is measured as the ratio of CRS technical effi-
ciency scores and VRS technical efficiency scores.45
When it comes to DEA studies comparing countries, 
both the input-oriented and output-oriented models 
have been adopted for analysis. An output-oriented 
DEA model aims to maximise the outputs with a given 
amount of inputs, while input-oriented models focus on 
minimising the inputs used to obtain a certain amount of 
output. Many studies have been carried out using DEA to 
assess the efficiency of healthcare systems using the two 
approaches in both high-income and low-income coun-
tries.28 46–48 In this study, an output-oriented DEA model 
was deemed more appropriate based on the premise 
that the input (ie, per capita expenditure) is likely to 
be less flexible. In other words, health system stewards 
are likely to have more leverage in controlling outputs 
through innovative programming and improvements in 
provided healthcare, rather than by increasing spending 
and resources.
Output-oriented model
The output-oriented technical efficiency model focuses 
on increasing output without changing the quantity of 
inputs used. The objective of the model for solving each 
particular DMU (health system) is to maximise the effi-
ciency score (denoted  ϕ ) meaning the amount by which 
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all outputs can be improved for each country’s health 
system under consideration while holding input constant.
The output-oriented DEA model is specified as follows:
  Max ϕ =
∑
OrYrj0 + O0  
Subject to constraints:
 
 
m∑
i=1
Vi + Xij0 = 1
 
 
 
 
s∑
r=1
Or + Yrj −
∑
VrXij + O0 ≤ 0, j = 1, . . . ,n
 
 
  Or, Vi ≥ 0  
  O0 > 0, or O0 = 0 or O0 < 0;  
where,
Yrj=amount of output r from country j.
Xij=amount of input i to country j.
Or=weight given to output r.
Vi=weight given to input i.
n=number of countries.
s=number of outputs.
m=number of inputs.
O0 >0 defines increasing returns to scale, O0=0 defines 
CRS, and O0 <0 defines decreasing returns to scale.
The technical efficiency scores is defined by  ϕ  and, it 
ranges between 0.00 and 1.00; if it is equal to 1.00, then 
the production from the DMU is efficient; while if it is less 
than 1.00, the DMU is inefficient.
Explaining efficiency through regression analysis
One of the limitations of the DEA approach is the serial 
correlation of the efficiency scores generated through 
this approach. In other words, the correlation between 
inputs and outputs, and consequently with the estimated 
efficiency scores resulted in this serial correlation. Thus, 
the scores of one DMU is not independent on that of 
the other DMUs. To handle this limitation, scholars 
such as Ramalho et al49 and McDonald50 have argued 
that econometric models like probit, logit and truncated 
regression (Tobit) can be used for second-stage analysis 
for identifying impact of environmental variables on 
efficiency. However, scholars such as Simar and Wilson51 
have argued that the conventional statistical inferences 
are inappropriate in the second-stage regression due to 
the bias of the DEA score and recommend using boot-
strap methods.51 Afonso and St. Aubyn52 showed in their 
empirical study that the censored normal Tobit regres-
sion and bootstrap algorithms yield very similar results. 
However, we have adopted both the Tobit model and 
smoothed bootstrap model in explaining the association 
with health system efficiency to be comprehensive.
The VRS efficiency scores computed using the DEA 
model were regressed against a few health service produc-
tions (eg, physician and beds density per 1000 popula-
tion) and some environmental factors (table 1). Since, by 
definition, the DEA scores range between 0 and 1, and 
some of the data tend to concentrate on these boundary 
values (ie, censored for the DMUs with a value at one), 
ordinary least squares cannot estimate the regression. 
Therefore, a Tobit model is suitable for such regres-
sion. For the convenience of calculation, we assumed a 
censoring point at zero in this model. As a result, the effi-
cient DMUs will have a score of zero, and the inefficient 
DMUs will have score greater than zero. Following Zere,53 
we applied this method by transforming VRS technical 
efficiency scores into VRS inefficiency scores and leaving 
censoring at 0 as follows.
 
 
Inefficiency score =
(
1
VRS technical efficiency score
)
− 1
 
 
The Tobit regression model used variables representing 
access to healthcare and health status. Guided by several 
similar studies, physician density (the number of physi-
cians per 1000 population) and bed density (the number 
of inpatient beds per 1000 population) were selected 
as determinants of access to healthcare.35 54 In addition 
to healthcare, the health status of individuals is deter-
mined by the lifestyle and behaviours; therefore, we also 
included two environmental factors as determinants of 
Table 1 Descriptive statistics of input, outcome, and explanatory variables
Characteristics/description Mean Median SD Minimum Maximum Source
Input variable
  Health expenditure per capita, PPP 1133.71 663.94 1157.72 88.03 4405.13 WDI
Outcome variables
  Healthy life expectancy at birth (years) 64.29 65.2 5.1 53.2 75.9 WHO
  Infant mortality (per 1000 live births) 19.9 13.9 15.8 2.0 65.7 WDI
Explanatory variables for Tobit model
  Physicians (per 1000 people) 1.6 1.6 1.1 0.1 4.8 WDI
  Hospital beds (per 1000 people) 2.9 2.1 2.7 0.1 13.7 WDI
  Smoking prevalence, males (% of adults) 42.2 42.2 10.5 18.9 71.8 WDI
  Primary completion rate, total (% of relevant age group) 96.5 97.9 11.4 66.7 116.5 WDI
PPP, purchasing power parity; SD, standard deviation; WDI, World Development Indicators-2015.
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efficiency, namely smoking prevalence among adult male 
(percentage of adults) and primary education comple-
tion rate of relevant age group. The relevant age group 
for the primary completion rate is defined as the number 
of new entrants (enrolments minus repeaters) in the last 
grade of primary education (regardless of age), divided 
by the population at the entrance age for the last grade 
of primary education of a country.55 The adverse health 
effect of smoking consequently affects health outcomes 
and also the health system efficiency.25 52 56 Education 
is found to be an important factor in determining indi-
vidual health status. Higher educational attainment is 
associated with higher income which, in turn, secures a 
healthy living environment and access to healthcare.57 
Additionally, we included population density (population 
living per square kilometre of land area) as the control of 
efficiency. This is because population density can affect 
the quality of healthcare services.
The Tobit regression models were specified as follows:
 
 
Ineffi =
β0 + β1 Phyi + β2 Bedsi + β3 Primary_edui+
β4 Smokingi + β5 Inci + β5 Pop_densityi + εi  
 
where,
Ineff=the technical inefficiency score; continuous 
variable.
Phy=physician density; categorical variable (1=fewer 
than one physician; 2=1–2 physicians, 3=more than two 
physicians).
Beds=beds density; categorical variable (1=fewer than 
one bed, 2=more than one to less than or equal to three 
beds, 3=more than three to less than or equal to five beds, 
4=more than five beds).
Inc=income group of the country; categorical variable 
(1=low- and lower middle-income, 2=upper middle-in-
come, 3=high-income).
Pop_density=population density; categorical variable 
(1=fewer than or equal to 100, 2=more than 100 to less 
than or equal to 200, 3=more than 200).
Finally, ε i was the stochastic error term. 
We submitted the initial DEA scores in a smoothed 
bootstrap method design by Simar and Wilson51 to esti-
mate the robust efficiency score from the bootstrapped 
regression analysis to identify factors associated with these 
scores. The simarwilson command in STATA V.13 was 
applied in the analysis using externally estimated DEA 
scores (algorithm #1).58
Sensitivity analysis
The efficiency scores can be affected by the number 
of inputs and outputs used in DEA in relation with the 
number of DMUs. The scores can be overestimated if 
the number of DMUs is relatively small compared with 
the number of inputs or very large compared with the 
number of inputs and outputs.59 60 It is suggested that 
the number of DMUs should be at least three times of 
the inputs and outputs variables.61 62 In our model, the 
number of DMUs46 is more than three times of the 
number of inputs and outputs,9 and this is not a binding 
constraint for this study.
There is a possibility that choosing different variables 
in the DEA model may produce inconsistent results such 
as inconsistent efficiency estimate. There is no test to 
assess the suitability of a particular model specification in 
DEA.63 Therefore, we carried out a sensitivity analysis of 
the efficiency scores by running the DEA model several 
times using different combinations of input and outcome 
variables. Different specifications of the DEA models 
were considered (eg, dropping the efficient countries, 
using HALE at age 60 years as input, using health expen-
diture per capita at current US$ as input, and excluding 
countries with any missing variable for the year 2015) for 
testing the sensitivity of our main model.
Patient and public involvement
The study used secondary data from WHO and WDI 
databases. No patients were involved in this study. Study 
findings will be shared with the stakeholders, including 
local community groups in community meetings and at 
national or regional conferences.
results
The descriptive statistics of the selected input, outcome 
and environmental variables are shown in table 1. The 
per capita health expenditure ranges from a minimum 
of US$88.03 (Bangladesh) to a maximum of US$4405.13 
(Japan) with a mean, median,  and SD of 1133.71, 663.94 
and 1157.72 respectively. The number of physicians per 
1000 people ranges from a minimum of 0.1 at Timor-
Leste to maximum 4.8 at Georgia. However, the number 
of inpatient beds per 1000 people is the smallest in 
Iran (0.1) and the highest in Japan (13.7). The average 
smoking prevalence of the adult male people among the 
studied countries is 42.2% and average primary educa-
tion completion rate is 96.5% of the relevant age group.
Among the countries analysed, HALE at birth was a 
minimum of 53.2 years in Afghanistan and a maximum of 
75.9 years in Singapore. The infant mortality rate ranged 
from 2.0 deaths per 1000 live births in Japan to 65.7 
deaths per 1000 live births in Pakistan. On average, there 
were 19.9 deaths per 1000 live births in the studied coun-
tries. The scatter matrix of the input and output variables 
Figure 1 Association across health systems input and 
outcome.
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Table 2 Technical and scale efficiency scores of the health systems in Asian countries
Country name CRS technical efficiency VRS technical efficiency Scale efficiency Returns to scale
Afghanistan 0.724 0.812 0.891 1
Armenia 0.769 0.946 0.813 −1
Azerbaijan 0.660 0.902 0.732 −1
Bahrain 0.714 0.910 0.784 −1
Bangladesh 1.000 1.000 1.000 0
Bhutan 0.775 0.903 0.858 1
Brunei Darussalam 0.708 0.920 0.769 −1
Cambodia 0.805 0.916 0.879 1
China 0.806 0.975 0.826 −1
Cyprus 1.000 1.000 1.000 0
Georgia 0.751 0.923 0.813 −1
India 0.778 0.892 0.872 1
Indonesia 0.746 0.904 0.826 1
Iran 0.678 0.900 0.754 −1
Iraq 0.683 0.850 0.803 1
Israel 0.874 0.967 0.904 −1
Japan 1.000 1.000 1.000 0
Jordan 0.743 0.943 0.789 −1
Kazakhstan 0.695 0.882 0.788 1
South Korea 0.886 0.972 0.911 −1
Kuwait 0.674 0.885 0.762 −1
Kyrgyz Republic 0.806 0.941 0.856 1
Laos 0.818 0.889 0.920 1
Lebanon 0.746 0.910 0.820 1
Malaysia 0.778 0.927 0.839 1
Maldives 0.730 0.944 0.773 −1
Mongolia 0.737 0.896 0.823 1
Myanmar 0.743 0.872 0.852 1
Nepal 0.861 0.932 0.924 1
Oman 0.692 0.896 0.772 −1
Pakistan 0.827 0.889 0.930 1
Philippines 0.779 0.916 0.850 1
Qatar 0.677 0.903 0.749 −1
Saudi Arabia 0.624 0.871 0.716 −1
Singapore 1.000 1.000 1.000 0
Sri Lanka 0.904 0.985 0.917 −1
Syria 0.818 0.848 0.964 1
Tajikistan 0.856 0.964 0.888 −1
Thailand 0.791 0.956 0.828 −1
Timor-Leste 0.823 0.903 0.912 1
Turkey 0.710 0.916 0.776 −1
Turkmenistan 0.639 0.859 0.743 1
United Arab  
Emirates
0.691 0.889 0.777 1
Uzbekistan 0.784 0.947 0.828 −1
Continued
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shows that inputs, for instance, increase in per-capita 
healthcare expenditure was associated with improved 
health outcomes (eg, HALE at birth and reduced infant 
mortality) (figure 1).
The mean CRS and VRS technical efficiency scores 
were 0.780 and 0.919, respectively (table 2). Whereas, the 
mean scale efficiency score was 0.847. Considering VRS 
efficiency, Afghanistan has the lowest score of 0.812. Both 
VRS and CRS technical efficiency scores were positively 
correlated with per capita health expenditure, HALE 
at birth and negatively correlated with infant mortality 
(online supplementary table 1).
Out of 46 countries studied, only four (8.7%) coun-
tries showed the maximum level of efficiency (efficiency 
score 1.00) in VRS and CRS technical efficiency scale. All 
of these four countries showed scale efficiency of 1.00 
implying that these countries created the best practice 
frontier based on their input and output combinations. 
Around 39.1% (18 countries) of the studied countries 
showed increasing returns to scale, 52.2% countries 
(24 countries) showed decreasing returns to scale and 
four efficient countries showed CRS production function 
of their health systems.
More than half of the countries (30 countries) had VRS 
efficiency, and five countries had CRS efficiency greater 
than 90% (online supplementary figure 1).
result from tobit regression and bootstrap analysis for 
associated factors with the inefficiency
Tobit regression and smoothed bootstrap were used to 
relate VRS efficiency scores to two health service produc-
tion variables and four environmental variables in two 
separate models (table 3). Negative associations with the 
inefficiency scores in the Tobit model represent positive 
relation of health system efficiency with the explanatory 
variables. However, positive associations with the explana-
tory variables in the smoothed bootstrap model represent 
positive relations of the health system efficiency with the 
explanatory variables.
Physician density, income status of countries and 
smoking prevalence among males exhibited statistically 
insignificant associations with the health system efficiency 
in the both models. The density of bed (more than three to 
fewer than or equal to five) had a significantly negative 
association with the inefficiency scores (ie, positive asso-
ciation with the efficiency) compared with less than one 
bed density category. Countries having more than one 
and less than or equal to three bed density had no signif-
icant association with the inefficiency scores. However, 
after the bootstrapping, this category became significant 
and the significance level increased for the rest two cate-
gories (ie, more than three and less than or equal to five 
bed density and more than five bed density). The asso-
ciation of bed density in the both models indicates that 
sample countries with less than one bed density have 
lower technical efficiency of their health systems. Further-
more, the primary education completion rate was signifi-
cantly negatively associated with the inefficiency score 
in the Tobit model, which indicates that countries with 
higher percentage of primary education completion rate 
have higher health system efficiency. Similar association 
was observed in the bootstrap model. In case of popula-
tion density, we found in the both models that countries 
having more than 200 population per square kilometre 
were more efficient in their health system efficiency 
compared with the countries with less than or equal to 
100 population per square kilometre.
Sensitivity of the efficiency scores
We conducted sensitivity analysis using various combina-
tions of input and output variables. In all of these cases, 
the average of the efficiency scores varied from 0.812 to 
0.936. The most sensitive combination was found while 
using the HALE at age 60 years as the outcome variable. 
The efficiency score changed from 0.919 (main model) 
to 0.812 (considering input as HALE at age 60 years) 
(figure 2).
In table 4, mean efficiency scores are presented by the 
income categories of the countries. The highest mean 
VRS technical efficiency were observed for high-income 
countries (0.934; 95% CI 0.905 to 0.963), followed by 
upper middle-income (0.914; 95% CI 0.894 to 0.935), 
and low and lower middle income countries (0.913; 
95% CI 0.891 to 0.935). If all the health systems oper-
ated at maximum efficiency at their given input level, 
the high-income, upper middle-income, low-income 
and lower middle-income countries could improve their 
Country name CRS technical efficiency VRS technical efficiency Scale efficiency Returns to scale
Vietnam 0.845 0.996 0.849 −1
Yemen 0.727 0.826 0.881 1
Mean (95% CI) 0.780 (0.752 to 0.808) 0.919 (0.905 to 0.933) 0.847 (0.824 to 0.87)   –
Median 0.772 0.913 0.834 – 
Minimum 0.624 0.812 0.716 – 
Maximum 1 1 1 – 
CRS, constant returns to scale; VRS, variable returns to scale.
Table 2 Continued 
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health system outcome (eg, HALE at birth and reduce 
infant mortality) by 6.6%, 8.6% and 8.7% respectively.
disCussiOn
The main findings of this paper demonstrated that about 
91.3% of the studied Asian countries are technically inef-
ficient with respect to using healthcare systems resources 
(using a proxy of per capita health expenditure). The 
study findings showed that among the studied Asian coun-
tries, the majority of the efficient countries belonged to the 
high-income group (Cyprus, Japan and Singapore). Only 
one country belonged to the low- and lower middle-income 
group (Bangladesh). Among the 46 countries studied, only 
four countries (Bangladesh, Japan, Singapore and Cyprus) 
showed CRS efficiency, indicating that they were operating 
at their most efficient level. Of the 14 high-income coun-
tries studied, nine countries (75.0%) had health system 
production at decreasing returns to scale. This implies that 
although the highest number of efficient countries belonged 
to the high-income group, a large number of these coun-
tries’ health system production had more resources than 
the ideal situation. A similar situation was observed for the 
upper middle-income countries. Of the 13 countries, 10 
(76.9%) had decreasing returns to scale. Only 5 (23.8%) out 
of 21 low-income and lower middle-income countries were 
producing at decreasing returns to scale. Although these 
low-income and lower middle-income countries are not effi-
cient, most of their production follows increasing returns to 
scale.
It was observed that the average of the efficiency scores 
increased from the low-income and lower middle-income 
countries to high-income countries. An important policy 
implication of this study could be that the technically inef-
ficient low-income and lower-middle income countries on 
average can improve their health systems outcome by 8.7%, 
middle-income country by 8.6% and high-income country 
by 6.6% using the existing levels of per-capita health expen-
diture. An international study found a similar conclusion 
that health systems performance is most efficient in the 
developed countries according to simple efficiency scores.64
The overall healthcare efficiency in different countries 
varied considerably.65 66 Among the low-income and lower 
middle-income countries studied, one country demon-
strated the most efficient health systems (Bangladesh). This 
country has both technical and scale efficient health systems, 
like the high-income countries (Japan, Singapore, and 
Cyprus).67 A possible reason for the high efficiency of this 
Figure 2 Results from the sensitivity analysis of efficiency scores. CRS, constant returns to scale; DMUs, decision-making 
units; VRS, variable returns to scale.
Table 4 Mean efficiency scores according to income level 
of Asian countries
Income groups
VRS technical efficiency Percentage of 
output can be 
improved in 
VRS technical 
efficiency, %Mean 95% CI
Low income 
and lower 
middle income
0.913 (0.891 to 0.935) 8.7
Upper middle 
income
0.914 (0.894 to 0.935) 8.6
High income 0.934 (0.905 to 0.963) 6.6
VRS, variable returns to scale.
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country could be a focus on infant mortality and child health 
as prioritised in past Millennium Development Goals and 
in current Sustainable Development Goals agendas, which 
relates to the outcome variables used in this study.
The DEA result showed that more than 60% of the low-in-
come and lower middle-income countries had health system 
efficiency greater than 90%. This result implies that these 
countries produce good health at low cost and therefore 
make good use of health systems resources.68 This result 
suggests that it is possible for countries to have a high-effi-
ciency score with poor health outcomes because of their low 
expenditure on resources and increasing returns to scale 
production function. In other words, given their moderate 
consumption of inputs and challenging social environments, 
these countries can achieve good health outcomes, relative 
to the other countries. Similar findings were observed for 
Mexico and Turkey relative to other countries in a study of 
the OECD countries.39 It should be noted that this study 
only used per-capita health expenditure and there are other 
factors that influence health outcomes as well. For example, 
differences in life expectancy and infant mortality between 
populations can be due to lifestyles, preferences56 69 70 social 
class, occupation71 and environmental factors.72 73 On a 
more macroscopic level, the results could also be impacted 
by a variety of contextual factors among countries such as 
different political institutions, economic landscapes, health-
seeking behaviour patterns and burden of diseases among 
other things. However, in this study, we attempted to address 
by including variables addressing the number of physicians, 
number of inpatient beds and population density, along with 
two environmental factors namely primary completion rate 
of relevant age group and smoking prevalence among the 
adult male population to take into consideration some of 
this variation. The results showed that more than three and 
less than five beds per 1000 population significantly influ-
enced the efficiency score. A low number of beds cannot 
serve a large proportion of the population and therefore the 
systems may be inefficient. Similarly, a high number of beds 
may often be left unused and make the health systems inef-
ficient. The countries having more than 200 people living 
per square kilometre had a higher level of efficiency in their 
health systems.
A limitation of DEA methodology is that it works in a 
deterministic way, meaning that the results entirely depend 
on the numeric values in the dataset. As the DEA approach 
compares DMUs, the number and nature of DMUs in the 
data set can noticeably change the results. For example, if a 
more efficient country is added to the dataset, it would move 
the frontier, causing some of the efficiency scores of other 
countries to fall. This is a key aspect of the methodology 
used.
Additionally, it is important to note that the use of a 
different set of variables might have generated different 
conclusions. In the future, if additional data become avail-
able for a larger number of countries in the region, the 
number of variables analysed could be increased to include 
an understanding with a greater degree of complexity in 
health system efficiency.
Another data limitation is the comparability of health 
expenditures among the Asian countries. While recognising 
that it is not possible to solve the inherent issues, we made an 
attempt to minimise it. Since the actual amount of health-
care expenditure across different countries may not be 
comparable due to the difference in purchasing power parity 
across countries, we used health expenditures as constant of 
2011 in PPP as an input in the DEA model.39 Also, when we 
included health expenditure at current USD per capita as an 
input in the DEA model, we found that the efficiency score 
did not change significantly.
We applied sensitivity analysis in an attempt to overcome 
these limitations (figure 2). Our results were consistent while 
using several combinations of inputs and outputs variables, 
which is reassuring and strengthens the findings from this 
study.
COnClusiOns
This study provides an empirical picture of the technical effi-
ciency of the healthcare systems of 46 Asian countries. The 
study shows that inefficiency exists in the healthcare systems 
of most of the countries studied; however, the results point 
to three high-income and one lower middle-income country, 
which efficiently used healthcare systems resources. The 
interpretation of the inefficient countries identified through 
this study is that they can improve health outcomes using 
the current level of per-capita health expenditure. These 
countries could use these results to direct their attention 
to benchmarking their health systems within their regional 
or another comparative group in order to understand their 
health system performance in a more detailed way. This 
study addresses the need to understand efficiency issues, as 
well as potentially identify good examples of countries that 
efficiently allocate and use resources to make their health-
care systems more technically efficient. It narrows a gap in 
the literature as there are few countries studying healthcare 
efficiency in Asia and looking comparatively in this manner.
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